Criteria and Forms
Icahn School of Medicine's Policies on Intellectual Property: Ownership and Commercial Development provides that any invention developed at the Medical School or resulting from research conducted at the Medical School should be disclosed the School and is owned by the School in the first instance. The Policies also provide for sharing commercialization income with the inventors and innovators. MSSM has one of the most generous policies in the country for sharing income. For more details see the Faculty Handbook.
We encourage you to contact us as soon as you have an idea you'd like to discuss. If warranted we will encourage you to submit a Technology Disclosure Form [PDF]. This form provides a detailed description of the invention or discovery, its state of development, the names of the inventors and contributors, and other helpful information in performing a Preliminary Evaluation of the commercial potential, patentability, and path to market of the invention. Faculty and staff are also asked to provide critical information re the source of funding for the work leading to the idea, so that MSSM can fulfill its responsibilities to the sponsor (including reporting of federally-funded inventions to the government).
Once the OTBD receives the Disclosure Form, a docket number is assigned to the technology and information relating to the technology is entered into Inteum, OTBD's technology management software system. The technology is assigned to an Asset Manager with relevant background and experience regarding the field of the invention. The Asset Manager makes an initial assessment of the technology, contacts the inventor(s), and works with them to complete Preliminary Evaluation. This may be an interactive process during which the Asset Manager conducts patent searches as well as conducts preliminary market assessments with the input of external or internal team members. Once the Preliminary Evaluation is completed, the initial assessment is reviewed by the OTBD team, the recommendation of the Asset Manager is taken into consideration and a decision is made to advance the invention through investment of MSSM resources in intellectual property protection, further development of the idea internally or externally if additional work need to be done to address critical questions, or advise the inventor(s) the commercial value (despite the excellent science) is not sufficient to warrant further action or investment.